SCHEMBL7045154

SCHEMBL7045154

Cc1ccc(OC(=O)c2c3ccccc3nc3ccccc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.56
TP53 P04637 1/20 0.56
ALDH1A1 P00352 1/20 0.55
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 3/20 0.51
GAA P10253 3/20 0.51
POLB P06746 3/20 0.51
MEN1 O00255 2/20 0.51
MAPK1 P28482 2/20 0.51
KDM4E B2RXH2 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
PDE10A Q9Y233 1/20 0.47
LMNA P02545 1/20 0.47
USP2 O75604 1/20 0.47
MCL1 Q07820 1/20 0.47
PTK2B Q14289 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705535 0.89 MAPT (0.50) MAPTALDH1A1NPC1RAB9AKMT2A
SCHEMBL8149705 0.88 MAPT (0.56) MAPTTP53ALDH1A1NPC1RAB9A
SCHEMBL8150632 0.85 POLB (0.51) MAPTALDH1A1NPC1RAB9AKMT2A
SCHEMBL8151119 0.84 MAPT (0.55) MAPTTP53ALDH1A1NPC1RAB9A
SCHEMBL7797045 0.84 MAPT (0.48) MAPTTP53ALDH1A1NPC1RAB9A
SCHEMBL27475817 0.84 KMT2A (0.51) MAPTALDH1A1RAB9AKMT2AMEN1
SCHEMBL7046974 0.84 TP53 (0.59) MAPTTP53ALDH1A1NPC1RAB9A
SCHEMBL7020881 0.81 MAPT (0.51) MAPTTP53ALDH1A1NPC1RAB9A
SCHEMBL7888286 0.81 MAPT (0.42) MAPTTP53ALDH1A1NPC1RAB9A
SCHEMBL2986968 0.80 MAPT (0.46) MAPTTP53ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822233-B2 Ultra-sensitive chemiluminescent substrates for enzymes and their conjugates GIRI BRIJ PAL (US) 2014-09-02 US disclosed
US-8546150-B2 Ultra-sensitive chemiluminescent substrates for enzymes and their conjugates Michigan Diagnostics, L.L.C. (US) 2013-10-01 US disclosed
US-20100317122-A1 NEW ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES GIRI BRIJ PAL 2010-12-16 US disclosed
US-20100317031-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES GIRI BRIJ PAL 2010-12-16 US disclosed
US-20100317877-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES GIRI BRIJ PAL 2010-12-16 US disclosed
US-7781229-B2 water-soluble, stable in aqueous buffers, for use in biological assaying include acridane-based compounds and (1,2)-dioxetanes; used in the detection of antibodies or antigen in biological fluids and for compounds, particularly toxins and contaminants in the environment and food. MICHIGAN DIAGNOSTICS, LLC (US) 2010-08-24 US disclosed
US-20070225498-A1 water-soluble, stable in aqueous buffers, for use in biological assaying include acridane-based compounds and (1,2)-dioxetanes; used in the detection of antibodies or antigen in biological fluids and for compounds, particularly toxins and contaminants in the environment and food. MICHIGAN DIAGNOSTICS, LLC 2007-09-27 US disclosed
EP-0609885-B1 Acridinium compounds and conjugates thereof MOCHIDA PHARM CO LTD (JP) 2003-04-16 EP disclosed
US-5594112-A CHEMILUMINESCENCE LABEL MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1997-01-14 US disclosed
US-5438139-A Chemiluminescent; useful as immunolochemical, DNA probe and receptor bininding assays MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1995-08-01 US disclosed
EP-0609885-A1 Acridinium compounds and conjugates thereof MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1994-08-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317877-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES DUOX1, XDH, MPO MAPT 3336/4885TP53 2467/4885ALDH1A1 69/4885
US-20070225498-A1 water-soluble, stable in aqueous buffers, for use in biological assaying include acridane-based compounds and (1,2)-dioxetanes; used in the detection of antibodies or antigen in biological fluids and for compounds, particularly toxins and contaminants in the environment and food. BTD, DDT, LPO MAPT 4025/4885TP53 467/4885ALDH1A1 205/4885
US-20100317031-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES DUOX1, XDH, MPO MAPT 3382/4885TP53 2628/4885ALDH1A1 76/4885
US-20100317122-A1 NEW ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES DUOX1, XDH, LPO MAPT 3534/4885TP53 2741/4885ALDH1A1 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.